Mein Warenkorb

B6R (MPXV)

B6R (MPXV) Produktliste

  • Attribut

    Protein (1)Antibody (1)

  • Produktbibliothek

    Online (2)

  • Spezies

    Monkeypox virus (Democratic Republic of the Congo) (1)Mouse (1)

  • Etikett

    His Tag (1)- (1)

  • Marker

    Unconjugated (2)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Mouse
HEK293
Monoclonal Anti-Monkeypox virus (Democratic Republic of the Congo) B6R Antibody, Mouse IgG1 (4E5) (MALS verified) In den Warenkorb legen
Monkeypox virus (Democratic Republic of the Congo)
HEK293
Monkeypox virus (Democratic Republic of the Congo) B6R Protein, His Tag (MALS verified) In den Warenkorb legen
Gesamtmenge2
  • 1

B6R (MPXV) Molekülhintergrund

Monkeypox is a rare zoonosis caused by monkeypox virus, which has become the most serious orthpoxvirus and consists of complex double stranded DNA. The pathogenesis of monkeypox is that the virus invades the body from respiratory mucosa, multiplies in lymphocytes, and incurs into blood producing transient venereal toxemia. after the virus multiplies in cells, the cells can invade the blood and propagate to the skin of the whole body, causing lesions. B6R, located both on the membranes of infected cells and on the enveloped virion (EV) envelope, is similar to the complement control protein-like B5R of the vaccinia virus.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BranaplamLMI-070; NVS-SM1Phase 2 ClinicalNovartis Pharma AgHuntington Disease; Muscular Atrophy, Spinal
Details
vesemnogene lantuparvovec (Lantu Biopharma)AAV-hSMN1Phase 2 ClinicalLantu Biopharma IncMuscular Atrophy, Spinal
Details
EXG001-307EXG001-307Phase 2 ClinicalHangzhou Jiayin Biotechnology Co LtdMuscular Atrophy, Spinal
Details
SMN-C3SMN-C3Phase 1 ClinicalPtc Therapeutics Inc, F. Hoffmann-La Roche LtdMuscular Atrophy, Spinal
Details
SKG-0201SKG0201; SKG-0201Phase 1 ClinicalSkyline Therapeutics (Hong Kong) LtdSpinal Muscular Atrophies of Childhood; Muscular Atrophy, Spinal
Details
BIIB-115BIIB-115; ION-306Phase 1 ClinicalIonis Pharmaceuticals IncMuscular Atrophy, Spinal
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
RisdiplamRG-7916; RO-7034067ApprovedPtc Therapeutics IncEVRYSDI, 艾满欣United StatesMuscular Atrophy, SpinalGenentech Inc2020-08-07Muscular Atrophy, Spinal
Details
Nusinersen sodiumBIIB-058; ISIS-396443ApprovedIonis Pharmaceuticals Inc, Biogen IncSpinrazaUnited StatesMuscular Atrophy, SpinalBiogen Idec2016-12-23Muscular Atrophy, Spinal
Details
Onasemnogene abeparvovecrAAV-9; AVXS-101; scAAV-9.CB.SMN; OAV101ApprovedNovartis Gene Therapies Inc, Novartis Pharma AgZolgensmaUnited StatesMuscular Atrophy, SpinalNovartis Gene Therapies Inc2019-05-24Spinal Muscular Atrophies of Childhood; Muscular Atrophy, Spinal
Details
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns